Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins
- 9 November 2016
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 18 (5) , 1795-1809
Abstract
Econazole nitrate (EC) is an active, imidazole antifungal agent. However, low aqueous solubility and dissolution rate of EC has discouraged its usage for the treatment of ophthalmic fungal infection. In this study, inclusion complexes of EC with cyclodextrins were prepared to enhance its solubility, dissolution, and ocular bioavailability. To achieve this goal, EC was complexed with β-CyD/HP-β-CyD using kneading, co-precipitation, and freeze-drying techniques. Phase-solubility studies were performed to investigate the complexes in the liquid form. Additionally, the complexes in the solid form were characterized with Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and transmission electron microscopy (TEM). Furthermore, different eye drops containing EC-CyD complexes were prepared using different polymers and then characterized regarding their drug contents, pH, viscosity, mucoadhesive strength, and in vitro release characteristics. The results showed that stable EC-CyD complexes were formed in 1:1 molar ratio as designated by BS-type diagram. Econazole nitrate water solubility was significantly increased in about three- and fourfold for β-CyD and HP-β-CyD, respectively. The results showed that the prepared complexes were spherical in shape having an average particle diameter from 110 to 288.33 nm with entrapment efficiency ranging from 64.24 to 95.27%. DSC investigations showed the formation of real inclusion complexes obtained with co-precipitation technique. From the in vitro studies, all eye drops containing co-precipitate complexes exhibited higher release rate than that of other complexes and followed the diffusion-controlled mechanism. In vivo study proved that eye drops containing EC-CyD complexes showed higher ocular bioavailability than EC alone which indicated by higher AUC, Cmax, and relative bioavailability values.Keywords
This publication has 48 references indexed in Scilit:
- Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug deliveryInternational Journal of Pharmaceutics, 2011
- Polymeric nanoparticulate system: A potential approach for ocular drug deliveryJournal of Controlled Release, 2009
- Simultaneous determination of econazole nitrate, main impurities and preservatives in cream formulation by high performance liquid chromatographyTalanta, 2008
- Recent Perspectives in Ocular Drug DeliveryPharmaceutical Research, 2008
- Cyclodextrins in drug delivery: An updated reviewAAPS PharmSciTech, 2005
- Studies on a new device for drug delivery to the eyeEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Study on the inclusion complexes of bromazepam with β- and β-hydroxypropyl-cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 2002
- Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eyeActa Ophthalmologica Scandinavica, 2002
- Bactericidal and inhibitory effects of azole antifungal compounds onMycobacterium smegmatisFEMS Microbiology Letters, 2000
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996